Wenli Zhang

Diosmetin alleviated cerebral ischemia/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1/Nrf2 signaling pathway.

Yihui Deng, Lipeng Du, Zhigang Mei, 2021, Food & function.

An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases.

Jiyong Liu, Jinwen Ge, Zhigang Mei, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions

Yujiao Lu, Quanguang Zhang, D. Brann, 2018, Molecular Neurobiology.

Sanpian decoction ameliorates cerebral ischemia-reperfusion injury by regulating SIRT1/ERK/HIF-1α pathway through in silico analysis and experimental validation.

Zhitao Feng, Ya-nan Luo, Lipeng Du, 2023, Journal of ethnopharmacology.

Neutrophil Extracellular Traps in Cerebral Ischemia/Reperfusion Injury: Friend and Foe

Zhigang Mei, Yueqin Zhou, Wenli Zhang, 2023, Current neuropharmacology.

Novel insight into the role of A-kinase anchoring proteins (AKAPs) in ischemic stroke and therapeutic potentials.

Zhigang Mei, Wenli Zhang, Xuan Wei, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Metabolic Reprogramming in Gliocyte Post-cerebral Ischemia/ Reperfusion: From Pathophysiology to Therapeutic Potential

Zhigang Mei, Wenli Zhang, Letian Xie, 2024, Current neuropharmacology.

Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia–reperfusion injury

Zhigang Mei, Xiangyu Chen, Tong Yang, 2024, CNS neuroscience & therapeutics.

Novel insight into the therapeutical potential of flavonoids from traditional Chinese medicine against cerebral ischemia/reperfusion injury

Zhigang Mei, Wenli Zhang, Feiyue Sun, 2024, Frontiers in pharmacology.